亿帆医药2025年度分红派息实施公告——投资者须知
关键要点概述
- 分红方案通过：亿帆医药股份有限公司（证券代码：002019）2025年度利润分配方案已于2026年5月18日年度股东会审议通过。
- 分红方案具体内容：以公司现有总股本1,216,390,085股为基数，向全体股东每10股派现金1元（含税），合计派发现金121,639,008.50元。不送红股，也不以资本公积金转增股本。
- 股本未变化：自方案披露至实施期间，公司股本总额未发生变化，若未来有变化将调整每股分配比例，总额保持不变。
- 分红税务细则：不同持股类型及持股期限对应不同税率，涉及境外投资者、QFII、RQFII、个人及基金等，分红税务政策详细见下文。
- 重要日期：
- 股权登记日：2026年5月28日
- 除权除息日：2026年5月29日
- 分红派息到账日：2026年5月29日
- 分红对象：截止2026年5月28日深圳证券交易所收市后，在中国证券登记结算有限责任公司深圳分公司登记在册的全部股东。
- 分红派发方式：大部分A股股东由中国结算深圳分公司代派，部分股东由公司自行派发。
- 咨询及备查文件：公司提供详细咨询方式及备查文件清单。
分红方案详细解读
亿帆医药本次分红派息以1,216,390,085股为基数，每10股派发现金1元人民币（含税）。分红总额为121,639,008.50元，且不送红股、不转增股本。对于境外投资者（包括深股通持股、QFII、RQFII）、首发前限售股的个人和证券投资基金，每10股派0.9元（扣税后）；首发后限售股、股权激励限售股及无限售流通股的个人红利税实行差别化税率，暂不扣缴个人所得税，待个人转让股票时再根据其持股期限计算应纳税额：
- 持股1个月（含1个月）以内：每10股补缴税款0.2元
- 持股1个月以上至1年（含1年）：每10股补缴税款0.1元
- 持股超过1年：无需补缴税款
此政策将影响个人投资者实际到手分红金额，持股时间越长，税负越低。
分红派发方式及具体流程
大部分A股股东的现金红利将由中国结算深圳分公司于2026年5月29日通过股东托管证券公司或其他托管机构直接划入资金账户。部分特殊股东（如程先锋及2022年员工持股计划账户）由公司自行派发现金红利。若自派股东证券账户内股份减少而导致委托代派现金红利不足的，法律责任由公司承担。
对股东的重要提示及投资影响
- 分红政策稳定：公司维持分红总额不变，显示出良好的现金流和盈利能力，对投资者信心有正面影响。
- 税收政策变动：差别化税率对个人投资者实际收益影响较大，尤其是短期持股者税负较高，可能影响投资者持股结构和交易行为。
- 分红到账及时：分红派息到账日为除权除息日当天，资金流动性强，利于投资者资金安排。
- 分红方案与往年一致：方案与股东会审议方案一致，且距离股东会审议通过时间未超过两个月，显示公司治理规范。
- 价格敏感信息：分红比例、税收政策、分红总额等均为价格敏感信息，可能对公司股价产生短期波动，投资者需关注除权除息日及税务政策变化。
公司联系方式及备查文件
投资者如有疑问可联系公司：
- 地址：安徽省合肥市肥西县桃花镇迎江寺路与繁华大道交口，亿帆医药股份有限公司
- 联系人：冯德崎、李蕾
- 电话：0551-62652019
- 传真：0551-66100530
备查文件包括年度股东会决议、董事会决议及分红派息时间安排确认文件。
结论
亿帆医药2025年度分红派息方案显示公司经营稳健，现金流充裕，分红政策对投资者有积极影响。差别化税率政策可能影响个人投资者实际收益，尤其是短期持股者。投资者应关注除权除息日的股价变动及税务细则，合理安排持股期限以优化收益。
免责声明
本文章内容仅供投资者参考，不构成任何投资建议。投资者需自行判断及承担风险。请关注公司后续公告及政策变化。
Yifan Pharma 2025 Annual Dividend Distribution Announcement – Investor Details
Key Points
- Dividend Plan Approved: Yifan Pharma (stock code: 002019) 2025 annual profit distribution plan approved at the shareholders’ meeting on May 18, 2026.
- Dividend Details: Based on total share capital of 1,216,390,085 shares, every 10 shares receive RMB 1 in cash (tax included). Total cash dividend distributed: RMB 121,639,008.50. No bonus shares, no capital reserve conversion.
- No Change in Share Capital: Share capital unchanged from disclosure to implementation. If changed, per share ratio adjusts but total dividend remains the same.
- Tax Policy: Different rates for foreign investors, QFII, RQFII, individuals, and funds. See below for detailed dividend tax policy.
- Important Dates:
- Shareholder Record Date: May 28, 2026
- Ex-dividend Date: May 29, 2026
- Dividend Payment Date: May 29, 2026
- Eligible Shareholders: All shareholders registered by the closing of Shenzhen Stock Exchange on May 28, 2026 at China Securities Depository Shenzhen Branch.
- Distribution Method: Most A-share holders paid via CSDC Shenzhen Branch, some paid directly by the company.
- Contact & Documentation: Company provides detailed contact and reference documents list.
Dividend Plan Details
Yifan Pharma will distribute cash dividends based on 1,216,390,085 shares, RMB 1 per 10 shares (tax included). Total payout: RMB 121,639,008.50. No bonus shares or capital reserve conversion. For foreign investors (including Hong Kong via Stock Connect, QFII, RQFII), pre-IPO restricted shares held by individuals and funds, after-tax dividend is RMB 0.9 per 10 shares; post-IPO restricted shares, equity incentive restricted shares, and unrestricted circulating shares held by individuals: differential tax rates apply, no withholding, tax calculated upon sale based on holding period:
- Holding ≤1 month: pay RMB 0.2 tax per 10 shares
- Holding >1 month ≤1 year: pay RMB 0.1 tax per 10 shares
- Holding >1 year: no additional tax
This policy will affect actual dividend received, with longer holding periods reducing tax burden.
Distribution Process
Most A-share holders will receive cash dividends via CSDC Shenzhen Branch through their broker or custody institution on May 29, 2026. Certain shareholders (e.g., Cheng Xianfeng, 2022 Employee Shareholding Plan) will receive dividends directly from the company. Any shortfall in cash dividends due to a decrease in self-distributed shareholder shares is the company’s responsibility.
Investor Tips & Impact
- Stable Dividend Policy: Dividend total remains unchanged, reflecting strong cash flow and profitability, positive for investor confidence.
- Tax Policy Shift: Differential tax rates impact actual dividend for individuals, especially short-term holders, possibly affecting holding structure and trading behavior.
- Prompt Dividend Payment: Dividend paid on ex-dividend day, improving liquidity.
- Consistent Policy: Distribution plan matches shareholders’ meeting approval, shows good governance.
- Price Sensitive Information: Dividend ratio, tax policy, total payout are price sensitive and may cause short-term share price fluctuation. Investors should monitor ex-dividend day and tax policy changes.
Contact & Reference Documents
For questions, contact:
- Address: Yifan Pharma, Yingjiang Temple Road & Fanhua Avenue Junction, Taohuazhen, Feixi County, Hefei, Anhui
- Contact: Feng Deqi, Li Lei
- Phone: 0551-62652019
- Fax: 0551-66100530
Reference documents include shareholders meeting resolution, board meeting resolution, and CSDC Shenzhen Branch confirmation of dividend payment schedule.
Conclusion
Yifan Pharma’s 2025 dividend plan shows stable operations and strong cash flow. Differential tax rates may impact actual dividend, especially for short-term holders. Investors should monitor ex-dividend date and tax details to optimize returns.
Disclaimer
This article is for information only and does not constitute investment advice. Investors should assess risks independently and follow subsequent company disclosures and policy changes.